Extended Data Table 1 Comparison of baseline characteristics of the at-risk and low-risk populations in the EP-STAR trial and the no-RAT external cohort
From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma

From: Risk-adaptive therapy guided by dynamic ctDNA in nasopharyngeal carcinoma
